Alto Neuroscience SEC Filing Effectiveness

Ticker: ANRO · Form: EFFECT · Filed: Apr 21, 2026 · CIK: 0001999480

Alto Neuroscience, Inc. EFFECT Filing Summary
FieldDetail
CompanyAlto Neuroscience, Inc. (ANRO)
Form TypeEFFECT
Filed DateApr 21, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: registration-statement, effectiveness, sec-filing

TL;DR

Alto Neuroscience's registration statement is now effective. Big news for their next move.

AI Summary

Alto Neuroscience, Inc. filed an EFFECT form on April 21, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001257, pertains to Act 33 and File No. 333-294974. The company's principal office is located at 650 Castro Street, Suite 450, Mountain View, CA 94041.

Why It Matters

This filing signifies that a registration statement for Alto Neuroscience, Inc. has become effective, which is a crucial step for certain securities offerings or corporate actions.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming the effectiveness of a registration statement, not indicating new financial risks.

Key Numbers

  • 2026-04-21 — Filing Date (Date the EFFECT filing was accepted by the SEC.)
  • 2026-04-20 — Effectiveness Date (The date the registration statement became effective.)

Key Players & Entities

  • Alto Neuroscience, Inc. (company) — Filer
  • 9999999995-26-001257 (dollar_amount) — SEC Accession Number
  • 2026-04-21 (dollar_amount) — Filing Acceptance Date
  • 2026-04-20 (dollar_amount) — Effectiveness Date
  • 333-294974 (dollar_amount) — File Number
  • 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 (dollar_amount) — Company Address

FAQ

What is the purpose of an EFFECT filing?

An EFFECT filing signifies that a registration statement filed with the SEC has become effective, allowing for the sale of securities or other actions outlined in the statement.

When did Alto Neuroscience's registration statement become effective?

The registration statement for Alto Neuroscience, Inc. became effective on April 20, 2026.

What is the SEC accession number for this filing?

The SEC accession number for this filing is 9999999995-26-001257.

What is Alto Neuroscience's business address?

Alto Neuroscience, Inc.'s business address is 650 Castro Street, Suite 450, Mountain View, CA 94041.

What is the file number associated with this registration statement?

The file number associated with this registration statement is 333-294974.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 21, 2026 regarding Alto Neuroscience, Inc. (ANRO).

View full filing on EDGAR

View Full Filing

View this EFFECT filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.